10/15/2022
Adam's 10/14 Coronavirus data update:
TL;DR: For now at least, cases seem to be flat to slowly decreasing, but new developments with several new variants could change that, perhaps within 3 weeks or so.
See below for some additional graphs on wastewater levels - they also show flat-ish levels overall, however higher levels and increases in the U.S. Northeast, which may be related to the higher levels of new variants there (see below).
On the variant picture, there were A BUNCH of updates from the CDC site and see graphs below. Basically, there are 6 variants being watched most closely, and BQ.1.1/BQ.1 are probably the ones to keep the closest eye on and most likely to have an impact the soonest. As a summary of each:
- BQ.1.1 (subvariant of BA.5) has been flagged by several experts as concerning in terms of immune escape and otherwise. The good news at least is that it is a subvariant of BA.5 and so the new bivalent vaccines should hopefully provide at least some protection. It is at around 5% of cases in the U.S./CA but as high as 8% in the Northeast and doubling or even more each week. At the current pace it will be the dominant variant in the U.S. in 3 weeks (Nov 5), though increases may slow down as its share increases so may be more like mid-Nov.
- BQ.1 is closely related to BQ.1, also around 5% but at 12% in the Northeast, and growing around 70-80% per week. On track to be dominant week of Nov 12, in 4 weeks, but may be competing closely with BQ.1.1 and rate of increase may slow down pushing it later.
- BA.4.6 was previously tracked closely and was increasing around 8% per week, and while it is now around 12% of cases, it is not really growing anymore, being outcompeted by BQ.1 , BQ.1.1 and perhaps others.
- BA.2.75.2 was sort of tracked but now broken out separately. It is around 1.4% and growing at 40% per week - on track to be over 50% by mid-Dec but may well get outcompeted by BQ.1/BQ.1.1
- BF.7 (subvariant of BA.5) was also tracked and is at 5% and growing at 25% per week and also on track to be at over 50% by mid-Dec, but also likely to be out-competed.
- XBB (subvariant of BA.2) has been identified elsewhere as concerning, but is not being tracked and is presumably not at significant levels, at least not yet, in the U.S.
On the variant side, BA.4.6 still increasing slowly at 7% per week and now at a 13.6% share. BA.2.75 has slowed a lot and is still at just 1.8% share. BF.7 (subvariant of BA.5) is increasing a fair amount at 40% per week though is still at a 4.6% share.
Bivalent vaccine booster for ages 5-11 expected to be approved some time in the next week.
1) Israel 7-day new cases are decreasing 10-15% per week.
2) Italy 7-day new cases increases are slowing down, now increasing at 10-15% per week.
3) UK 7-day new cases may be plateauing.
4) South Africa 7-day new cases are steady at around a 0.5 case rate.
5) The U.S. 7-day new cases have now flattened out at a case rate of around 12.
6) CA 7-day new cases continue to decrease around 10% per week, now at a case rate of around 10.
7) San Diego new cases decreased again, down 15-20% from last week and now at a case rate of around 8.
8 ) LA 7-day new cases are decreasing at around 10% per week, now at a case rate of around 11.
9) SF Bay Area 7-day new cases are decreasing at around 10% per week, now at a case rate of around 8.